REVIEW
|
doi:10.20944/preprints202410.0449.v1
Subject:
Dermatology,
Medicine And Pharmacology
Keywords:
atopic dermatitis; treatment; quality of life; disease burden; therapy; economic costs; psychological aspects; daily activities; JAK inhibitors; biologics; dupilumab; atopic eczema
Online: 7 October 2024 (09:31:14 CEST)